chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Nasal congestion, Vaccination site pain
Clinical narrative: Lethargy; Pain at injection site; Congestion; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Feb2021 at 09:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, anxiety, depression and atrial fibrillation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), loratadine (CLARITIN), bupropion hydrochloride (WELLBUTRIN) and nadolol (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 13:00 the patient experienced lethargy, pain at injection site and congestion (nasal congestion). Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lethargy, pain at injection site and congestion was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gait inability, Headache, Pain, SARS-CoV-2 antibody test
Clinical narrative: Chills; Shaking so hard; "I" could barely walk; Headache of massive pain; Body aches like "I" have never before; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 12:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), hydrochlorothiazide, olmesartan medoxomil (OLMESARTAN/HYDROCHLOROTHIAZIDE) and levocetirizine (MANUFACTURER UNKNOWN); all for an unknown indication from unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 04Feb2021 at 16:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021 at 00:30, the patient symptoms were as described on line, but very severe. The patient experienced chills with shaking so hard that she could barely walk, a headache of massive pain, body aches like she had never had before, so much worse than flu.  Shaking lasted for 1 hour, the other symptoms for 18 hours. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antibody test (Blood test) and the result was negative. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events shaking was recovered on 26Feb2021 at 01:30 and chills, so hard that she could barely walk, a headache of massive pain, body aches like she had never had before, so much worse than flu was recovered on 26Feb2021 at 18:30, after the duration of 18 hours.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Chills; Shaking so hard; "I" could barely walk; Headache of massive pain; Body aches like "I" have never before; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 12:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), hydrochlorothiazide, olmesartan medoxomil (OLMESARTAN/HYDROCHLOROTHIAZIDE) and levocetirizine (MANUFACTURER UNKNOWN); all for an unknown indication from unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 04Feb2021 at 16:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021 at 00:30, the patient symptoms were as described on line, but very severe. The patient experienced chills with shaking so hard that she could barely walk, a headache of massive pain, body aches like she had never had before, so much worse than flu.  Shaking lasted for 1 hour, the other symptoms for 18 hours. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antibody test (Blood test) and the result was negative. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events shaking was recovered on 26Feb2021 at 01:30 and chills, so hard that she could barely walk, a headache of massive pain, body aches like she had never had before, so much worse than flu was recovered on 26Feb2021 at 18:30, after the duration of 18 hours.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Headache, Malaise, Pain in extremity
Clinical narrative: Very sore arm, painful to lift and lay on; Strong fatigue/ tired; General feeling of unwellness; Possibly a little chilled; Headache; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENU198) via an unspecified route of administration in the left arm on 28Feb2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included mild traumatic brain injury, hypothyroidism, cold intolerance, and mononucleosis. The patient had known allergies to eggs when she was a baby so not sure if she still has the allergy and possibly penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ethinylestradiol/ drospirenone (NIKKI), lactobacillus acidophilus (FLORAJEN), and fibre/dietary (BENEFIBER); all for an unknown indication from an unknown dates and unknown if ongoing. On 28Feb2021 at 12:45, the patient experienced very sore arm, painful to lift and lay on, strong fatigue, so that the patient had to take nearly a 3 hours nap and was still tired afterwards. The patient experienced a general feeling of unwellness, possibly a little chilled (as she was having hypothyroidism so was having cold intolerance). The patient had no fever and photophobia. The patient tried getting a headache but it never amounted to anything. On 01Mar2021 (reported as the next day), her arm soreness has gotten a lot better but was still present. The patient was trying to get a headache again but has not amounted to anything yet. She was still a little tired but not as bad as yesterday (28Feb2021). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events very sore arm, painful to lift and lay on, strong fatigue/ tired, general feeling of unwellness, possibly a little chilled, and headache were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: hearing problems; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program with Regulatory Authority Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, on 18Feb2021 (lot number not reported), as dose 1, single, for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, after the first dose, the patient had hearing problems. On 11Mar2021, the patient received the second dose of BNT162B2. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Visual impairment
Clinical narrative: Headache; Blur in center of visual field and pulsing rim ofwhite triangles, affecting both eyes; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Feb2021 at 09:15 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. Medical history included The patient had no known allergies to medications, food or other products allergic respiratory symptom, allergy to molds and penicillin allergy. Concomitant medications included acetylsalicylic acid (ASPIRIN). The patient previously received azithromycin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 the patient experienced blur in center of visual field and pulsing rim of white triangles, affecting both eyes. On 26Feb2021 at 10:15 the patient experienced Headache. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Blur in center of visual field and pulsing rim of white triangles, affecting both eyes and Headache was resolved.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain from shoulders to fingers; Pain from top of legs to toes; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CN6202) via an unspecified route of administration in the right arm on 26Feb2021 at 09:45 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included Atrial Fibrillation (AFib), depression and osteoarthritis. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FL9269) via an unspecified route of administration in the right arm on 05Feb2021 at 09:00 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021 at 18:00, the patient experienced pain from shoulders to fingers and pain from top of legs to toes. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain from shoulders to fingers and pain from top of legs to toes was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nausea; This is a spontaneous report from a Pfizer-sponsored program received from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was previously administered with first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunisation. On an unspecified date, the patient experienced nausea after the second dose. Outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: taste buds have been off; This is a spontaneous report from a non-contactable consumer (patient) from a sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on an unspecified date in 2021 at dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient stated that his taste buds have been off since the vaccination. He was asking if this was normal. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Malaise
Clinical narrative: Weakness; Painful stomach; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 26Feb2021 at 08:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation (Afib), obesity, high cholesterol and hypothyroidism start from an unknown date, unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medication included drug not specified too many to list (as reported). On 27Feb2021 at 20:00 the patient experienced weakness, painful stomach and malaise. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events weakness, painful stomach and malaise were recovering at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysstasia, Fatigue
Clinical narrative: Shakes and shivers; Hard to stand; Tired; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04Feb2021 at 15:30 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to various foods, dust, pollens and dander. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was healthy and did not take any medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Feb2021, on the day 1 of vaccination the patient was tired and  on 05Feb2021, day 2 the patient experienced shakes and shivers that lasted for one and half hours and the patient had hard to stand. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tired and hard to stand were recovered on an unknown date in Feb2021 while the event shakes and shivers was recovered on 05Feb2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Feb2021 at 16:30 (at the age of 78-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Joint lock
Clinical narrative: Right shoulder locks up; BNT162B2 was administered before 19 days of previous dose; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the right arm on 22Feb2021 at 14:00 (at the age of 69-years-old) as a single dose of COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 16Feb2021 (at the age of 69-years-old) as a single dose of COVID-19 immunisation. On 23Feb2021 at 14:30, the patient's right shoulder locked up. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right shoulder locks up was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extreme exhaustion; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for COVID-19 immunization. The patient experienced extreme exhaustion on unspecified date (3 days after the second dose). The patient asked if it was normal to have extreme exhaustion after the second dose. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain
Clinical narrative: Sore body all over; Fatigued; Just felt unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 83-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Feb2021 at 16:00 (at the age of 83-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and diabetes. The patient was allergic to metropolis. Concomitant medications were not reported. The patient previously received niacin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Feb2021 at 06:00, the patient experienced sore body all over, fatigued, and just felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore body all over, fatigued and just felt unwell was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Diarrhoea, Fatigue, Musculoskeletal stiffness
Clinical narrative: Chills; Exhaustion; Stiff neck; Abdominal cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 27Feb2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer and allergy to opioids. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included anastrozole (MANUFACTURER UNKNOWN), valaciclovir (VALACYCLOVIR), vitamin d nos (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN) and ascorbic acid, copper, zinc, xantofyl, zeaxanthin, vitamin e nos (AREDS 2). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 14:30, the patient experienced chills, exhaustion, stiff neck, abdominal cramps, and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, exhaustion, stiff neck, abdominal cramps and diarrhea was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 28Feb2021 at 09:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL FE 1.5/30) for an unknown indication from an unknown date and unknown if ongoing. On 28Feb2021 at 20:30, the patient experienced diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea and nausea were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Pain in the right arm at and around the injection site.; Extreme soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 27Feb2021 at 09:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) and multivitamin; both taken for an unknown indication on an unknown date and unknown if ongoing. On 27Feb2021 at 09:30, the patient experienced extreme soreness/ pain in the right arm at and around the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event extreme soreness/pain in the right arm at and around the injection site was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Vomiting
Clinical narrative: Nausea on and off day after vaccine.; Fatigue; Chills; One episode of vomiting evening after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6202) via an unspecified route of administration in the left arm on 28Feb2021 at 09:45 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination. Concomitant medications included tetanus vaccine (MANUFACTURER UNKNOWN) taken on 08Feb2021 in the left arm for an unknown indication, amlodipine besilate (NORVASC), acetylsalicylic acid (ASA) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. On 28Feb2021, evening after vaccine, the patient experienced one episode of vomiting. On 01Mar2021 at 19:15, the patient experienced nausea on and off day after vaccine, fatigue and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea on and off day after vaccine, one episode of vomiting, fatigue and chills were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in upper arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 01Mar2021 at 09:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient did not receive other medications within 2 weeks of vaccination. On 01Mar2021 at 10:00, the patient experienced soreness in upper arm. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Feb2021 at 11:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 23Feb2021, the patient experienced sore arm and headache. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and headache was recovered on an unknown date in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Pyrexia
Clinical narrative: About four hours after injection, I experienced lightheadedness and chills; I experienced lightheadedness and chills; I decided to check my temp, assuming I would be feverish. Instead, one thermometer read 95.4 F and the other thermometer read 95.6 F; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 27Feb2021 at 11:45 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, latex allergy and fruit allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN) and hydroxyzine (MANUFACTURER UNKNOWN) taken for an unknown indication in an unknown date and unknown if ongoing. The patient previously received hydrocodone (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 17:00, about four hours after injection, the patient experienced lightheadedness and chills. The patient's husband (who did not receive the vaccine) noted that he felt warm, so the patient decided to check temperature, assuming would be feverish. Instead, one thermometer read 95.4 Degrees Fahrenheit and the other thermometer read 95.6 Degrees Fahrenheit. After wrapping up very warmly for a couple of hours, her temperature was normal again, but still experienced light headed for the rest of the day. On the same day, the patient underwent body temperature test and the result was 95.4 Degrees Fahrenheit and 95.6 Degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events lightheadedness, chills and feverish were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, SARS-CoV-2 test
Clinical narrative: Headache; Dizziness; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 20-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Feb2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included dexmethylphenidate hydrochloride (FOCALIN) and escitalopram oxalate (LEXAPRO); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Jan2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 22Feb2021 at 12:00, the patient experienced headache and dizziness after the second shot. Since the vaccination, the patient had been tested for COVID-19. On 22Feb2021, the patient underwent work COVID-19 test via nasal swab and the result was pending. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events headache and dizziness after the second shot was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 21Feb2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multi-vitamins (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Feb2021, the patient experienced sore arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolved on an unknown date in Feb2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Pain assessment
Clinical narrative: Abdominal pain; This is a spontaneous report from a non-contactable physician. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on 26Jan2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on an unspecified date for covid-19 immunization, flu vaccine and shingles vaccine. On 26Jan2021, the patient experienced abdominal pain. AE severity was "6-7 out of 10". The outcome of the event was recovered on 28Jan2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Severe headache; moderate fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Feb2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 16:00, the patient experienced severe headache and moderate fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache and moderate fatigue was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasal discomfort, Rhinorrhoea, Secretion discharge
Clinical narrative: Increased nasal congestion; mucous production; nasal mucous requiring frequent and productive nose blowing; It is an almost constant irritant; This is a spontaneous report from a contactable nurse, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1283) via an unspecified route of administration in the left arm on 10Jan2021 at 12:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS), gastroesophageal reflux disease (GERD) and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received an unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the left arm on 12Dec2020 at 00:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. On 17Jan2021 at 12:00, the patient experienced increased nasal congestion and mucous production which had continued for more than six weeks, with no other symptoms, no illness with just excessive nasal mucous requiring frequent and productive nose blowing and was almost constant irritant. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events increased nasal congestion, mucous production, nasal mucous requiring frequent and productive nose blowing, constant irritant were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Lymphadenopathy
Clinical narrative: Swollen lymph nodes 4 days after 2nd dose; Administration date 21Feb2021, dose number=2/ administration date 03Feb2021, dose number=1; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 21Feb2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. It was unknown if the patient had any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 25Feb2021 at 12:00, the patient experienced swollen lymph nodes, 4 days after the second dose. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: stomach cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 20Feb2021 at 17:00 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, irritable bowel syndrome and benign prostatic hyperplasia. The patient previously took barium (MANUFACTURER UNKNOWN) and esomeprazole sodium (NEXIUM) for an unknown indication from an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ), doxazosin mesilate (CARDURA), amitriptyline hydrochloride (AMITRIPTYLENE) and finasteride (FINASTERID); all taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the right arm on 29Jan2021 as a single dose for COVID-19 immunisation and experienced diarrhea and stomach cramps. On 20Feb2021 at 11:00 the patient experienced stomach cramps and diarrhea. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stomach cramps and diarrhea was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo, Vomiting
Clinical narrative: Dizziness that turned into vertigo andvomiting; Dizziness; Dizziness that turned into vertigo; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 25Feb2021 at 16:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included eosinophilia myalgia syndrome. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all for an unknown indication on an unknown dates and unknown if ongoing. On 26Feb2021, the patient experienced dizziness that turned into vertigo and vomiting. She also reported that the two episodes lasted about 20 minutes each. The vertigo was so bad that she could not see or function. If she had been driving she could have crashed. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, dizziness and vertigo were resolved on an unknown date in Feb2021 after the duration of 20 minutes.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.